SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

10 Feb 2022 Evaluate
The Total revenue for the quarter ended December 2021 of  Rs. 555.78 millions remain, more or less, the same.The Net Profit of the company vaulted to 319.45% to Rs. 64.47  millions from Rs. 15.37 millions in the previous quarter.The company reported a good operating profit of 88.36 millions compared to 25.44 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 555.78 549.41 1.16 1618.90 1317.05 22.92 1790.18 1374.53 30.24
Other Income 0.00 0.00 0.00 2.27 0.42 440.48 4.63 5.72 -19.06
PBIDT 88.36 25.44 247.33 146.39 68.63 113.30 91.31 72.02 26.78
Interest 1.26 3.62 -65.19 5.07 11.02 -53.99 12.77 9.78 30.57
PBDT 87.10 21.82 299.18 141.32 57.61 145.30 78.36 62.12 26.14
Depreciation 1.51 1.27 18.90 4.44 3.58 24.02 4.93 4.26 15.73
PBT 85.59 20.55 316.50 136.88 54.03 153.34 73.43 57.86 26.91
TAX 21.12 5.18 307.72 34.98 16.29 114.73 20.11 15.48 29.91
Deferred Tax -0.04 0.28 -114.29 1.40 3.24 -56.79 2.88 -1.77 -262.71
PAT 64.47 15.37 319.45 101.90 37.74 170.01 53.32 42.38 25.81
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 15.90 4.63 243.35 9.04 5.21 73.53 5.10 5.24 -2.65

Samrat Pharmachem Share Price

221.15 0.55 (0.25%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×